» Articles » PMID: 23969151

Assessment of Extent of Breast Cancer: Comparison Between Digital Breast Tomosynthesis and Full-field Digital Mammography

Overview
Journal Clin Radiol
Specialty Radiology
Date 2013 Aug 24
PMID 23969151
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Aim: To compare the accuracy of digital breast tomosynthesis (DBT) and full-field digital mammography (FFDM) in preoperative assessment of local extent of breast cancer.

Materials And Methods: Lesion sizes of breast cancers on DBT and FFDM images were independently evaluated by breast radiologists. Each lesion was flagged as either mis-sized or not depending on whether the assessment of size at imaging was within 1 cm of the lesion size at surgery. Additional analyses were made by mammographic parenchymal density and by lesion size, using 2 cm as the boundary to separate the two subgroups. Statistical comparisons were performed using a repeated measures linear model on the percent mis-sized. P-values < 0.05 were considered statistically significant.

Results: The dataset included 173 malignant breast lesions (mean size 23.8 mm, 43% of lesions were ≤2 cm in size) in 169 patients, two-thirds of which had heterogeneously or extremely dense breasts. Overall, the percentage of lesions mis-sized at DBT was significantly lower than at FFDM (19% versus 29%, p = 0.003). There was significantly less mis-sizing at DBT in both heterogeneously dense breasts (11.1% difference between DBT and FFDM, p = 0.016) and extremely dense breasts (15.8% difference, p = 0.024). DBT also had significantly less mis-sizing than FFDM in the subgroup of lesions that were ≤2 cm in size (14.7% difference, p = 0.005).

Conclusion: DBT was significantly superior to FFDM for the evaluation of lesion size overall, and specifically for small lesions and for lesions in dense breasts. The superiority of DBT versus FFDM increased with parenchymal density.

Citing Articles

Case report: An ultrasound-based approach as an easy tool to evaluate hormone receptor-positive HER-2-negative breast cancer in advanced/metastatic settings: preliminary data of the Plus-ENDO study.

Montella L, Di Marino L, Marino M, Riccio V, Del Gaudio N, Altucci L Front Oncol. 2024; 14:1295772.

PMID: 38690171 PMC: 11058846. DOI: 10.3389/fonc.2024.1295772.


The Role of Deep Learning in Advancing Breast Cancer Detection Using Different Imaging Modalities: A Systematic Review.

Madani M, Mahdi Behzadi M, Nabavi S Cancers (Basel). 2022; 14(21).

PMID: 36358753 PMC: 9655692. DOI: 10.3390/cancers14215334.


Utility of Digital Breast Tomosynthesis with Two-Dimensional Synthesized Mammography Images: A Pictorial Essay.

Hande P, Desai S, Arneja S, Sathian S Indian J Radiol Imaging. 2021; 31(3):678-688.

PMID: 34790314 PMC: 8590550. DOI: 10.1055/s-0041-1734378.


Assessment and Prediction of Response to Neoadjuvant Chemotherapy in Breast Cancer: A Comparison of Imaging Modalities and Future Perspectives.

Romeo V, Accardo G, Perillo T, Basso L, Garbino N, Nicolai E Cancers (Basel). 2021; 13(14).

PMID: 34298733 PMC: 8303777. DOI: 10.3390/cancers13143521.


Digital Breast Tomosynthesis: an Overview.

Dhamija E, Gulati M, Deo S, Gogia A, Hari S Indian J Surg Oncol. 2021; 12(2):315-329.

PMID: 34295076 PMC: 8272763. DOI: 10.1007/s13193-021-01310-y.